A Day Up For Cyclacel Pharmaceuticals, Inc.
Tue, Jul 15, 2025 at 07:15 PM
Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ) jumped higher at $12.33, a gain of 272.5%. On Tue, Jul 15, 2025, CYCC:NASDAQ touched a New 2-Week High of $12.33. The stock got featured on our News Catalysts scanner on Mon, Jul 07, 2025 at 07:57 AM in the 'AGREEMENT' category. From Tue, Jul 01, 2025, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Tue, Jul 15, 2025 at $19.24 with a volume of 62M+.
About Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ)
Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.
Top 10 Gainers:
- Cyclacel Pharmaceuticals, Inc. (CYCC:NASDAQ), 272.51%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 160%
- Longevity Health Holdings, Inc. (XAGE:NASDAQ), 115.5%
- Kairos Pharma, Ltd. (KAPA:NYSEMKT), 70.78%
- Trident Digital Tech Holdings Ltd (TDTH:NASDAQ), 59.03%
- Polyrizon Ltd. (PLRZ:NASDAQ), 52.47%
- Rich Sparkle Holdings Limited (ANPA:NASDAQ), 50.66%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%
- Pitanium Limited (PTNM:NASDAQ), 46.98%
- Zepp Health Corporation (ZEPP:NYSE), 46.29%